Why Diversity in Clinical Trials Is Essential to Advancing Rheumatology
Автор: Association of Women in Rheumatology AWIR
Загружено: 2026-01-19
Просмотров: 102
Описание:
True progress in rheumatology requires more than awareness—it requires action.
In this conversation, Dr. Catherine Bakewell discusses why diversity in clinical trials is critical to advancing science, improving patient trust, and ensuring treatments truly work for everyone. She explores the systemic barriers that limit representation, including disparities in access to care, historical mistrust, and the lack of diverse providers in research and clinical settings.
At AWIR, being “part of the solution” means identifying these challenges and addressing them head-on—so innovation in rheumatology reflects the communities it serves.
🎥 Watch to learn:
Why underrepresentation in clinical trials is a major issue
How trust and representation impact patient participation
Why diverse providers are essential to better science and better care
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
